SELL and COVID-19: Neutrophils from COVID-19 patients also showed increased CD11b levels [median MFI, 37 x104 (IQR 29 x 104-43 x 104) vs. 22 x 104 (IQR 17 x 104-31 x 104), p = 0.0002] and decreased CD62L levels [median MFI, 62 x 104 (IQR 57 x 104-69 x 104) vs. 90 x 104 (IQR 76 x 104-98 x 104), p < 0.0001, see Figure 3].